Preview

Pediatric pharmacology

Advanced search

The FDA has Approved Bozutinib for Children with Chronic Myelogenous Leukemia

About the Author

article Editorial

Russian Federation


Review

For citations:


The FDA has Approved Bozutinib for Children with Chronic Myelogenous Leukemia. Pediatric pharmacology. 2023;20(5):523. (In Russ.)

Views: 174


ISSN 1727-5776 (Print)
ISSN 2500-3089 (Online)